-
- Jukka Mäenpää
- AstraZeneca, Research and Development, Patient Safety, Respiratory, Inflammation, Autoimmunity, Infections and Vaccines Therapeutic Area, Gothenburg, Sweden
-
- Olavi Pelkonen
- Department of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland
書誌事項
- 公開日
- 2016-08-31
- DOI
-
- 10.1080/14740338.2016.1225718
- 公開者
- Informa UK Limited
この論文をさがす
収録刊行物
-
- Expert Opinion on Drug Safety
-
Expert Opinion on Drug Safety 15 (11), 1549-1561, 2016-08-31
Informa UK Limited